永顺生物 (839729.bj)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(永顺生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 66,495,478.87314,282,861.48252,920,068.67152,714,720.8981,091,529.35348,717,555.84254,511,982.81155,508,444.8378,677,625.48
 营业利润(元) 9,360,944.9961,103,036.7161,427,887.8440,910,248.7818,870,406.9395,899,699.0767,035,258.5938,910,422.9819,840,341.00
 利润总额(元) 9,420,501.3065,280,847.3165,597,008.1445,397,776.8923,804,973.7095,563,194.6667,736,399.9440,131,360.6419,848,262.18
 净利润(元) 8,374,511.5158,058,744.2557,737,233.3739,790,645.5520,894,809.4986,035,881.9459,347,338.2635,315,527.7917,329,287.65
 归属于母公司股东的净利润(元) 8,374,511.5158,058,744.2557,737,233.3739,790,645.5520,894,809.4986,035,881.9459,347,338.2635,315,527.7917,329,287.65
盈利能力:
 销售毛利率(%) 56.9658.8259.4662.1160.9062.5363.6964.6764.85
 销售净利率(%) 12.5918.4722.8326.0625.7724.6723.3222.7122.03
 净资产收益率(%) 1.218.518.576.052.91----
 总资产报酬率ROA(%) 1.007.457.445.292.69----
 投入资本回报率ROIC(%) 1.208.057.715.412.7211.798.295.032.42
营运能力:
 存货周转率(次) 0.723.302.951.280.83----
 应收账款周转率(次) 0.623.192.271.640.80----
 总资产周转率(次) 0.080.380.300.190.10----
偿债能力:
 资产负债率(%) 15.5815.1420.6920.4219.3019.8818.7518.2911.53
 股东权益比率(%) 84.4284.8679.3179.5880.7080.1281.2581.7188.47
 已获利息倍数(倍) -8.50-17.15-20.15-18.78-23.36-26.50-25.48-19.27-16.29
 流动比率 5.115.213.773.774.083.914.134.217.28
 速动比率 4.744.813.563.473.843.673.873.886.76
发展能力:
 营业收入增长率(%) -18.00-9.87-0.63-1.803.07-4.07-11.11-17.35-25.46
 营业利润增长率(%) -50.39-36.28-8.365.14-4.89-12.18-21.83-40.88-45.55
 税后利润增长率(%) -59.92-32.59-2.7112.6720.58-5.81-19.41-39.00-46.62
 净资产增长率(%) -4.81-3.96-1.71-2.07-1.60-1.31-1.14-1.16-0.26
 总资产增长率(%) -9.01-9.330.700.567.887.385.513.25-2.12

前瞻产业研究院